Cargando…
The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory
In a previous study the simple, naturally derived coumarin scopoletin (SCT) was identified as an inhibitor of acetylcholinesterase (AChE), using a pharmacophore-based virtual screening approach. In this study the potential of SCT as procholinergic and cognition-enhancing therapeutic was investigated...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212650/ https://www.ncbi.nlm.nih.gov/pubmed/21945033 http://dx.doi.org/10.1016/j.neuroscience.2011.09.006 |
_version_ | 1782216000848003072 |
---|---|
author | Hornick, A. Lieb, A. Vo, N.P. Rollinger, J.M. Stuppner, H. Prast, H. |
author_facet | Hornick, A. Lieb, A. Vo, N.P. Rollinger, J.M. Stuppner, H. Prast, H. |
author_sort | Hornick, A. |
collection | PubMed |
description | In a previous study the simple, naturally derived coumarin scopoletin (SCT) was identified as an inhibitor of acetylcholinesterase (AChE), using a pharmacophore-based virtual screening approach. In this study the potential of SCT as procholinergic and cognition-enhancing therapeutic was investigated in a more detailed way, using different experimental approaches like measuring newly synthesized acetylcholine (ACh) in synaptosomes, long-term potentiation (LTP) experiments in hippocampal slices, and behavior studies. SCT enhanced the K(+)-stimulated release of ACh from rat frontal cortex synaptosomes, showing a bell-shaped dose effect curve (E(max): 4 μM). This effect was blocked by the nicotinic ACh receptor (nAChR) antagonists mecamylamine (MEC) and dihydro-β-erythroidine (DHE). The nAChR agonist (and AChE inhibitor) galantamine induced a similar increase in ACh release (E(max): 1 μM). SCT potentiated LTP in hippocampal slices of rat brain. The high-frequency stimulation (HFS)-induced, N-methyl-D-aspartate (NMDA) receptor dependent LTP of field excitatory postsynaptic potentials at CA3-CA1 synapses was greatly enhanced by pre-HFS application of SCT (4 μM for 4 min). This effect was mimicked by nicotine (2 μM) and abolished by MEC, suggesting an effect on nAChRs. SCT did not restore the total inhibition of LTP by NMDA receptor antagonist d, l-2-amino-5-phosphonopentanoic acid (AP-5). SCT (2 μg, i.c.v.) increased T-maze alternation and ameliorated novel object recognition of mice with scopolamine-induced cholinergic deficit. It also reduced age-associated deficits in object memory of 15–18-month-old mice (2 mg/kg sc). Our findings suggest that SCT possesses memory-improving properties, which are based on its direct nAChR agonistic activity. Therefore, SCT might be able to rescue impaired cholinergic functions by enhancing nAChR-mediated release of neurotransmitters and promoting neural plasticity in hippocampus. |
format | Online Article Text |
id | pubmed-3212650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Elsevier Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32126502011-12-28 The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory Hornick, A. Lieb, A. Vo, N.P. Rollinger, J.M. Stuppner, H. Prast, H. Neuroscience Cognitive, Behavioral, and Systems Neuroscience In a previous study the simple, naturally derived coumarin scopoletin (SCT) was identified as an inhibitor of acetylcholinesterase (AChE), using a pharmacophore-based virtual screening approach. In this study the potential of SCT as procholinergic and cognition-enhancing therapeutic was investigated in a more detailed way, using different experimental approaches like measuring newly synthesized acetylcholine (ACh) in synaptosomes, long-term potentiation (LTP) experiments in hippocampal slices, and behavior studies. SCT enhanced the K(+)-stimulated release of ACh from rat frontal cortex synaptosomes, showing a bell-shaped dose effect curve (E(max): 4 μM). This effect was blocked by the nicotinic ACh receptor (nAChR) antagonists mecamylamine (MEC) and dihydro-β-erythroidine (DHE). The nAChR agonist (and AChE inhibitor) galantamine induced a similar increase in ACh release (E(max): 1 μM). SCT potentiated LTP in hippocampal slices of rat brain. The high-frequency stimulation (HFS)-induced, N-methyl-D-aspartate (NMDA) receptor dependent LTP of field excitatory postsynaptic potentials at CA3-CA1 synapses was greatly enhanced by pre-HFS application of SCT (4 μM for 4 min). This effect was mimicked by nicotine (2 μM) and abolished by MEC, suggesting an effect on nAChRs. SCT did not restore the total inhibition of LTP by NMDA receptor antagonist d, l-2-amino-5-phosphonopentanoic acid (AP-5). SCT (2 μg, i.c.v.) increased T-maze alternation and ameliorated novel object recognition of mice with scopolamine-induced cholinergic deficit. It also reduced age-associated deficits in object memory of 15–18-month-old mice (2 mg/kg sc). Our findings suggest that SCT possesses memory-improving properties, which are based on its direct nAChR agonistic activity. Therefore, SCT might be able to rescue impaired cholinergic functions by enhancing nAChR-mediated release of neurotransmitters and promoting neural plasticity in hippocampus. Elsevier Science 2011-12-01 /pmc/articles/PMC3212650/ /pubmed/21945033 http://dx.doi.org/10.1016/j.neuroscience.2011.09.006 Text en © 2011 Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/3.0/ Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license |
spellingShingle | Cognitive, Behavioral, and Systems Neuroscience Hornick, A. Lieb, A. Vo, N.P. Rollinger, J.M. Stuppner, H. Prast, H. The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory |
title | The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory |
title_full | The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory |
title_fullStr | The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory |
title_full_unstemmed | The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory |
title_short | The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory |
title_sort | coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory |
topic | Cognitive, Behavioral, and Systems Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212650/ https://www.ncbi.nlm.nih.gov/pubmed/21945033 http://dx.doi.org/10.1016/j.neuroscience.2011.09.006 |
work_keys_str_mv | AT hornicka thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT lieba thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT vonp thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT rollingerjm thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT stuppnerh thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT prasth thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT hornicka coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT lieba coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT vonp coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT rollingerjm coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT stuppnerh coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory AT prasth coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory |